Biomarker for early Inflammatory events and future Clinical outcomes in Inflammatory bowel disease based on a Systems biological Approach (BICISA)
Loss of interleukin 33 expression in colonic crypts - a potential marker for disease remission in ulcerative colitis
Sci Rep. 2016; 6: 35403.
Mucosal healing in active ulcerative colitis treated with infliximab to disease remission.
P-179. Poster presentation. 2015 Advances in Inflammatory Bowel Diseases, Crohn's&Colitis Foundation's Clinical and Research Conferance, Orlando, Florida.
Mucosal interleukin-33 levels in patients with moderate to severe ulcerative colitis before and after induction.........
Poster P039. J Crohns Colitis (2014) 8 (Supplement 1): S79-S80